| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |